Analysts on Wall Street project that Thermo Fisher Scientific (TMO) will announce quarterly earnings of $5.22 per share in its forthcoming report, representing a decline of 2.8% year over year. Revenues are projected to reach $10.65 billion, increasing 1% from the same quarter last year.The current level reflects an upward revision of 0.2% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial pro ...

核心财务预期 - 华尔街分析师预计Alphabet季度每股收益为2.14美元 同比增长13_2% [1] - 预计季度营收达792_5亿美元 同比增长11_1% [1] - 过去30天内共识EPS预期上调1_3% 反映分析师集体重新评估 [1] 收益预测重要性 - 收益预期变化是预测股票短期价格走势的关键因素 [2] - 历史研究显示收益预期修正趋势与股价表现存在强相关性 [2] 关键业务指标预测 - Google Properties收入预计618_6亿美元 同比增长8_2% [4] - Google Cloud收入预计130_4亿美元 同比增长26% [4] - YouTube广告收入预计94_7亿美元 同比增长9_3% [4] - Google广告总收入预计689_8亿美元 同比增长6_8% [5] - Google搜索及其他收入预计523_6亿美元 同比增长7_9% [5] - Google网络收入预计71_5亿美元 同比下降4% [5] 区域收入预测 - EMEA地区收入预计274_5亿美元 同比增长11_2% [6] - 美国收入预计447_4亿美元 同比增长8_6% [6] - 其他美洲地区收入预计54_2亿美元 同比增长9_7% [6] - APAC地区收入预计151_9亿美元 同比增长9_9% [7] 其他运营指标 - 总流量获取成本预计140_7亿美元 上年同期为133_9亿美元 [7] - 预计员工总数达185578人 上年同期为179582人 [8] - 过去一个月公司股价上涨5_9% 同期标普500指数上涨5_4% [8]

Wall Street analysts expect Freeport-McMoRan (FCX) to post quarterly earnings of $0.46 per share in its upcoming report, which indicates no change from the year-ago quarter. Revenues are expected to be $7.12 billion, up 7.5% from the year-ago quarter.Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted upward by 11% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.Ahead of a company's earning ...

In its upcoming report, Tesla (TSLA) is predicted by Wall Street analysts to post quarterly earnings of $0.40 per share, reflecting a decline of 23.1% compared to the same period last year. Revenues are forecasted to be $22.48 billion, representing a year-over-year decrease of 11.9%.Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 3.9% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this ...

Alphabet (GOOGL) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.Over the past month, shares of this internet search leader have returned +5.9%, compared to the Zacks S&P 500 composite's +5.4% change. During this period, the Zacks Internet - Services industry, which Alphabet falls in, has gained 4.9%. The key question now is: What could be the stock's future direction?While media relea ...

Townsquare Media (TSQ) shares ended the last trading session 6.9% higher at $9.05. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 19.5% gain over the past four weeks.Townsquare is benefiting from the expansion of its programmatic digital advertising services, growth in its subscription-based marketing platform, and partnerships with local media companies across underserved markets.This operator of radio stations i ...

One stock that might be an intriguing choice for investors right now is Amazon.com, Inc. (AMZN) . This is because this security in the Internet - Commerce space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective. This is important because, often times, a rising tide will lift all boats in an industry, as there can be broad trends taking place in a segment that are boosting securities across the board. This is arguably taking place in the Inter ...

Schlumberger (SLB) came out with quarterly earnings of $0.74 per share, beating the Zacks Consensus Estimate of $0.73 per share. This compares to earnings of $0.85 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +1.37%. A quarter ago, it was expected that this world's largest oilfield services company would post earnings of $0.74 per share when it actually produced earnings of $0.72, delivering a surprise of -2.7%.Over the las ...

公司业绩表现 - 公司季度每股收益为1.42美元 超出市场预期的1.23美元 但低于去年同期的1.53美元 [1] - 季度营收达8.49亿美元 超出市场预期的0.51% 同比增长3%至8.24亿美元 [2] - 过去四个季度中 公司三次超出每股收益预期 三次超出营收预期 [2] 市场表现与预期 - 公司股价年初至今上涨0.9% 落后于标普500指数7.1%的涨幅 [3] - 当前市场预期下季度每股收益1.32美元 营收8.562亿美元 全年每股收益5.08美元 营收33.9亿美元 [7] - 公司当前Zacks评级为3(持有) 预计未来表现与市场持平 [6] 行业比较 - 所属行业(大型区域性银行)在Zacks行业排名中位列前7% 行业前50%表现是后50%的两倍以上 [8] - 同业公司Northern Trust预计季度每股收益2.08美元 同比增长16.9% 但营收预计下降27%至19.8亿美元 [9][10] 业绩驱动因素 - 季度业绩超预期幅度达15.45% 前一季度超预期幅度为9.65% [1] - 未来股价走势将取决于管理层在财报电话会中的评论 [3] - 盈利预期修正趋势对短期股价有显著影响 [5]

股价表现 - Legend Biotech Corporation Sponsored ADR (LEGN) 股价在上一交易日飙升6%至42.13美元，成交量显著高于正常水平 [1] - 过去四周该股累计上涨13.9%，近期涨势可能源于投资者对Carvykti持续强劲销售的乐观预期 [1][2] 产品与研发 - Carvykti为公司与强生合作开发的一次性疗法，用于治疗复发或难治性多发性骨髓瘤，目前销售表现强劲 [2] - 公司拥有广泛的临床管线，涵盖多个处于不同研发阶段的肿瘤候选药物 [2] 财务预期 - 预计季度每股亏损0.18美元，同比恶化260%，但营收预计达2.3367亿美元，同比增长25.3% [3] - 过去30天内共识EPS预期上调4.1%，盈利预期修正趋势与股价走势呈正相关 [4] 行业对比 - 公司所属Zacks医疗-生物医学与遗传学行业，同业公司Vanda Pharmaceuticals (VNDA) 同期股价上涨1%至4.86美元，过去一个月回报率6.2% [4] - Vanda预计季度每股亏损0.34美元，同比恶化325%，但共识EPS预期过去一个月维持不变 [5]